CIK 0001326110
- Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 431979754
- Phone
- +1 844-696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- 4 Open-market sale Chief Financial Officer sold 16,364 shares at $15.00 ($245,460)
- 4 Open-market sale Chief Financial Officer sold 39,271 shares at $13.62 ($534,938)
- 4 Open-market sale See remarks sold 130,000 shares at $18.05 ($2,346,604)
- 4 Open-market sale Director sold 42,592 shares at $10.83 ($461,122)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 20,000 shares at $9.19 ($183,800)
- 4 Open-market sale Director sold 60,000 shares at an average $9.73 ($583,642)
- 4 Open-market sale Director sold 30,000 shares at $9.96 ($298,785)
- 4 Open-market sale Director sold 65,300 shares at an average $10.23 ($668,052)
- 4 Shares withheld for taxes Chief Financial Officer gave up 3,458 shares (to pay taxes)
- 4 Open-market sale See remarks sold 130,000 shares at an average $15.53 ($2,019,329)
- 4 Open-market sale See remarks sold 39,950 shares at $13.14 ($524,759)
- 4 Open-market sale See remarks sold 9 shares at $13.00 ($117)
- 4 Open-market buy Chairman and CEO bought 3,710,000 shares at $12.12 ($44,965,200)
- 4 Open-market sale See remarks sold 200,041 shares at an average $10.56 ($2,112,950)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 13 · 251 filings